English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/101502
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 8 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título

Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme

Autor Diez-Torrubia, Alberto ; Cabrera, Silvia ; Castro, Sonia de ; García-Aparicio, Carlos ; Mulder, Gwenn; De Meester, Ingrid; Camarasa Rius, María José ; Balzarini, Jan; Velázquez, Sonsoles ; Diez-Torrubia, Alberto
Palabras clave Acyclovir
Antiviral
Prodrug
Peptide
Solid-phase synthesis
Fecha de publicación 2013
EditorElsevier
Citación European Journal of Medicinal Chemistry 70: 456- 468 (2013)
ResumenWe herein report for the first time the successful use of the dipeptidyl peptidase IV (DPPIV/CD26) prodrug approach to guanine derivatives such as the antiviral acyclovir (ACV). The solution- and solid-phase synthesis of the tetrapeptide amide prodrug 3 and the tripeptide ester conjugate 4 of acyclovir are reported. The synthesis of the demanding tetrapeptide amide prodrug of ACV 3 was first established in solution and successfully transferred onto solid support by using Ellman's dihydropyran (DHP) resin. In contrast with the valyl ester prodrug (valacyclovir, VACV), the tetrapeptide amide prodrug 3 and the tripeptide ester conjugate 4 of ACV proved fully stable in PBS. Both prodrugs converted to VACV (for 4) or ACV (for 3) upon exposure to purified DPPIV/CD26 or human or bovine serum. Vildagliptin, a potent inhibitor of DPPIV/CD26 efficiently inhibited the DPPIV/CD26-catalysed hydrolysis reaction. Both amide and ester prodrugs of ACV showed pronounced anti-herpetic activity in cell culture and significantly improved the water solubility in comparison with the parent drug.
Versión del editorhttp://dx.doi.org/10.1016/j.ejmech.2013.10.001
URI http://hdl.handle.net/10261/101502
DOI10.1016/j.ejmech.2013.10.001
Identificadoresdoi: 10.1016/j.ejmech.2013.10.001
issn: 0223-5234
e-issn: 1768-3254
Aparece en las colecciones: (IQM) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.